Additional Information
Book Details
Abstract
A landmark guide to naturopathic practice in Australia – ideal for naturopaths, naturopathy students and Allied Health and medical practitioners
Clinical Naturopathy: An evidence-based guide to practice details key treatment protocols and evidence-based complementary medicine interventions for use in naturopathic practice.
This valuable naturopathy resource is authored by leading practitioners in the field. Its unique perspective combines clinical experience with evidence-based substantiation from rigorous medical research.
Clinical Naturopathy explores key naturopathic treatments – including herbal treatments, nutritional and dietary treatments and lifestyle treatments – for common medical symptoms and conditions encountered in modern practice.
Clinical Naturopathy: An evidence-based guide to practice outlines an introduction to case-taking methodology and naturopathic diagnostic techniques.
It then details treatment protocols and naturopathic prescriptions to treat major health conditions within individual body systems.
The textbook also offers special sections on naturopathic treatment throughout the life cycle, including paediatrics, pregnancy and aging, as well as complex health conditions like HIV, cancer and pain management.
Comprehensive appendices provide additional clinically important material, such as reference levels for laboratory medical tests, nutrient food values and traditional Chinese medical diagnosis.
This one-of-a-kind naturopathic reference makes essential reading for practitioners wishing to enhance practical application of their skills in a clinical setting, and advance their knowledge of evidence-based complementary medicine interventions.
• addresses pre-clinical and clinical naturopathy subjects (from third year naturopathy to post-graduate level)• focuses on major medical conditions, and outlines naturopathic and integrative medical treatments
• features case studies to contextualise theory into relevant clinical application
• includes user-friendly clinical decision trees, tables and figures
• is rigorously researched with over 4000 references
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover\r | Cover | ||
| Clinical Naturopathy:an evidence-based guideto practice | iii | ||
| Copyright\r | iv | ||
| CONTENTS | v | ||
| FOREWORD | ix | ||
| PREFACE | xiii | ||
| ACKNOWLEDGEMENTS | xvi | ||
| ABOUT THE EDITORS\r | xvii | ||
| CONTRIBUTORS | xviii | ||
| REVIEWERS | xxi | ||
| PART A\rNaturopathic clinical skills | 1 | ||
| Chapter 1 Naturopathic \rcase taking | 2 | ||
| NATUROPATHIC PHILOSOPHY AND PRINCIPLES | 2 | ||
| PATIENT-CENTRED APPROACH TO HOLISTIC CONSULTATION | 6 | ||
| STRUCTURE AND TECHNIQUE OF CASE TAKING | 8 | ||
| POSOLOGY | 13 | ||
| SIGNPOSTS FOR RECOVERY | 13 | ||
| CASE TAKING—THE RETURN VISIT | 14 | ||
| CASE TAKING—ADVANCED | 15 | ||
| Chapter 2\rNaturopathic diagnostic techniques | 19 | ||
| INTRODUCTION | 19 | ||
| EVIDENCE-BASED CLINICAL DIAGNOSTIC TECHNIQUES | 20 | ||
| FACTORS AFFECTING NUTRITIONAL STATUS | 33 | ||
| TRADITIONAL OR EMERGING DIAGNOSTIC TECHNIQUES | 34 | ||
| CHOOSING DIAGNOSTIC METHODS | 43 | ||
| PART B\rCommon clinical conditions | 49 | ||
| Section 1 Gastrointestinal system | 50 | ||
| Chapter 3\rIrritable bowel syndrome: constipation-predominant (C-IBS) | 52 | ||
| AETIOLOGY | 52 | ||
| RISK FACTORS | 53 | ||
| CONVENTIONAL TREATMENT | 53 | ||
| KEY TREATMENT PROTOCOLS | 53 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 64 | ||
| Chapter 4\rGastro-oesophageal reflux disease | 75 | ||
| AETIOLOGY | 75 | ||
| RISK FACTORS | 77 | ||
| CONVENTIONAL TREATMENT | 77 | ||
| KEY TREATMENT PROTOCOLS | 78 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 81 | ||
| Chapter 5\rFood allergy/intolerance | 88 | ||
| AETIOLOGY | 88 | ||
| RISK FACTORS | 89 | ||
| CONVENTIONAL TREATMENT | 90 | ||
| KEY TREATMENT PROTOCOLS | 90 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 95 | ||
| Section 2 Respiratory system | 102 | ||
| Chapter 6\rRespiratory infections and immune insufficiency | 104 | ||
| OVERVIEW | 104 | ||
| PATHOPHYSIOLOGY | 106 | ||
| CONVENTIONAL TREATMENT | 106 | ||
| KEY TREATMENT PROTOCOLS | 107 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 120 | ||
| Chapter 7\rAsthma | 132 | ||
| OVERVIEW AND AETIOLOGY | 132 | ||
| RISK FACTORS | 134 | ||
| CONVENTIONAL TREATMENT | 135 | ||
| KEY TREATMENT PROTOCOLS | 136 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 142 | ||
| Chapter 8\rCongestive respiratory disorders | 151 | ||
| OVERVIEW AND AETIOLOGY | 151 | ||
| RISK FACTORS | 151 | ||
| CONVENTIONAL TREATMENT | 152 | ||
| KEY TREATMENT PROTOCOLS | 152 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 161 | ||
| Section 3 Cardiovascular system | 171 | ||
| Chapter 9\rAtherosclerosis and dyslipidaemia | 173 | ||
| EPIDEMIOLOGY AND AETIOLOGY | 173 | ||
| RISK FACTORS | 176 | ||
| Conventional treatment | 177 | ||
| KEY TREATMENT PROTOCOLS | 178 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 184 | ||
| Chapter 10\rHypertension \rand stroke | 190 | ||
| EPIDEMIOLOGY AND AETIOLOGY | 190 | ||
| RISK FACTORS | 190 | ||
| CONVENTIONAL TREATMENT | 191 | ||
| KEY TREATMENT PROTOCOLS | 191 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 196 | ||
| Chapter 11\rChronic venous insufficiency | 203 | ||
| AETIOLOGY ANd epidemiology | 203 | ||
| RISK FACTORS | 203 | ||
| CONVENTIONAL TREATMENT | 204 | ||
| KEY TREATMENT PROTOCOLS | 205 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 207 | ||
| Section 4 Nervous system | 215 | ||
| Chapter 12\rClinical depression | 216 | ||
| CLASSIFICATION, EPIDEMIOLOGY AND AETIOLOGY | 216 | ||
| RISK FACTORS | 217 | ||
| CONVENTIONAL TREATMENT | 219 | ||
| KEY TREATMENT PROTOCOLS | 219 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 226 | ||
| Chapter 13\rChronic generalised anxiety | 238 | ||
| CLASSIFICATION, EPIDEMIOLOGY AND AETIOLOGY | 238 | ||
| RISK FACTORS | 239 | ||
| CONVENTIONAL TREATMENT | 240 | ||
| KEY TREATMENT PROTOCOLS | 240 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 245 | ||
| Chapter 14\rInsomnia | 257 | ||
| AETIOLOGY, CLASSIFICATION AND EPIDEMIOLOGY | 257 | ||
| RISK FACTORS AND ECONOMIC IMPACT | 258 | ||
| CONVENTIONAL TREATMENT | 259 | ||
| KEY TREATMENT PROTOCOLS | 260 | ||
| Section 5 Endocrine system\r | 274 | ||
| Chapter 15\rAdrenal exhaustion | 275 | ||
| AETIOLOGY | 275 | ||
| RISK FACTORS | 280 | ||
| CONVENTIONAL TREATMENT | 283 | ||
| KEY TREATMENT PROTOCOLS | 283 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 288 | ||
| Chapter 16\rDiabetes type 2 | 299 | ||
| AETIOLOGY | 299 | ||
| RISK FACTORS | 302 | ||
| CONVENTIONAL TREATMENT | 302 | ||
| KEY TREATMENT PROTOCOLS | 304 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 312 | ||
| Chapter 17\rThyroid abnormalities | 325 | ||
| AETIOLOGY | 325 | ||
| EPIDEMIOLOGY | 328 | ||
| RISK FACTORS | 329 | ||
| CONVENTIONAL TREATMENT | 331 | ||
| KEY TREATMENT PROTOCOLS | 333 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 337 | ||
| Section 6 Female reproductive system | 344 | ||
| Chapter 18\rDysmenorrhoea and menstrual complaints | 346 | ||
| AETIOLOGY AND CLASSIFICATION | 346 | ||
| RISK FACTORS | 349 | ||
| CONVENTIONAL TREATMENT | 349 | ||
| KEY TREATMENT PROTOCOLS | 349 | ||
| OTHER THERAPEUTIC CONSIDERATIONS | 353 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 354 | ||
| Chapter 19 \rEndometriosis | 363 | ||
| OVERVIEW AND AETIOLOGY | 363 | ||
| RISK FACTORS | 363 | ||
| CONVENTIONAL TREATMENT | 364 | ||
| KEY TREATMENT PROTOCOLS | 364 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 374 | ||
| Chapter 20\rPolycystic ovarian syndrome | 383 | ||
| CLASSIFICATION AND AETIOLOGY | 383 | ||
| RISK FACTORS | 384 | ||
| CONVENTIONAL TREATMENT | 385 | ||
| NATUROPATHIC DIAGNOSIS TECHNIQUES | 386 | ||
| KEY TREATMENT PROTOCOLS | 387 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 393 | ||
| Chapter 21\rMenopause | 401 | ||
| OVERVIEW | 401 | ||
| CONVENTIONAL TREATMENT | 403 | ||
| RISK FACTORS | 404 | ||
| KEY TREATMENT PROTOCOLS | 406 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 414 | ||
| Section 7 Musculoskeletal system | 420 | ||
| Chapter 22\rOsteoarthritis | 422 | ||
| DEFINITION AND AETIOLOGY | 422 | ||
| RISK FACTORS | 422 | ||
| DIAGNOSIS | 423 | ||
| CONVENTIONAL TREATMENT | 424 | ||
| KEY TREATMENT PROTOCOLS | 425 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 434 | ||
| Chapter 23\rFibromyalgia | 443 | ||
| AETIOLOGY, EPIDEMIOLOGY AND CLASSIFICATION | 443 | ||
| RISK FACTORS | 444 | ||
| CONVENTIONAL TREATMENT | 445 | ||
| KEY TREATMENT PROTOCOLS | 446 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 452 | ||
| Section 8 Integumentary system | 462 | ||
| Chapter 24\rAcne vulgaris | 463 | ||
| AETIOLOGY | 463 | ||
| RISK FACTORS | 463 | ||
| CONVENTIONAL TREATMENT | 464 | ||
| KEY TREATMENT PROTOCOLS | 465 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 470 | ||
| Chapter 25\rInflammatory skin disorders—atopic eczema and psoriasis | 477 | ||
| AETIOLOGY | 477 | ||
| RISK FACTORS | 478 | ||
| CONVENTIONAL TREATMENT | 479 | ||
| KEY TREATMENT PROTOCOLS | 479 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 486 | ||
| Section 9 Urogenital system | 494 | ||
| Chapter 26\rBenign prostatic hypertrophy | 495 | ||
| AETIOLOGY AND EPIDEMIOLOGY | 495 | ||
| RISK FACTORS1,3,16 | 497 | ||
| CONVENTIONAL TREATMENT | 497 | ||
| KEY TREATMENT PROTOCOLS | 498 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 504 | ||
| Chapter 27\rRecurrent urinary tract infection | 515 | ||
| AETIOLOGY AND EPIDEMIOLOGY | 515 | ||
| RISK FACTORS | 516 | ||
| CONVENTIONAL TREATMENT | 516 | ||
| KEY TREATMENT PROTOCOLS | 516 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 524 | ||
| PART C\rSpecialised clinical conditions | 529 | ||
| Chapter 28\rAutoimmunity | 530 | ||
| OVERVIEW | 530 | ||
| AETIOLOGY | 530 | ||
| RISK FACTORS | 538 | ||
| CONVENTIONAL TREATMENTS | 540 | ||
| KEY TREATMENT PROTOCOLS | 540 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 557 | ||
| Chapter 29\rCancer | 569 | ||
| AETIOLOGY | 569 | ||
| CANCER PREVENTION | 569 | ||
| CONVENTIONAL TREATMENT | 571 | ||
| CAM TREATMENT OF COMMON SIDE EFFECTS OF CHEMOTHERAPY AND RADIATION | 571 | ||
| POTENTIAL INTERACTIONS | 572 | ||
| RISK FACTORS | 573 | ||
| TUMOUR MARKERS | 574 | ||
| NATUROPATHIC APPROACHES TO CANCER PATHOPHYSIOLOGY | 574 | ||
| DIET AND CANCER | 579 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 580 | ||
| OVERVIEW | 588 | ||
| PART D\rClinical naturopathy across the life cycle | 601 | ||
| Chapter 30\rPaediatrics | 602 | ||
| OVERVIEW OF PAEDIATRIC CONSIDERATIONS | 602 | ||
| PAEDIATRIC MEDICATION CONSIDERATIONS | 603 | ||
| COMMON PAEDIATRIC CONDITIONS | 605 | ||
| COMPLIANCE ISSUES | 609 | ||
| Chapter 31\rFertility, preconception care and pregnancy | 622 | ||
| PRECONCEPTION CARE | 622 | ||
| CONVENTIONAL TREATMENT | 624 | ||
| RISK FACTORS | 625 | ||
| KEY TREATMENT PROTOCOLS | 626 | ||
| Dietary requirements | 635 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 643 | ||
| Chapter 32\rAgeing and cognition | 653 | ||
| OVERVIEW AND AETIOLOGY | 653 | ||
| RISK FACTORS | 660 | ||
| CONVENTIONAL TREATMENT | 660 | ||
| KEY TREATMENT PROTOCOLS | 661 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 667 | ||
| PART E\rIntegrative naturopathic practice | 679 | ||
| Chapter 33\rBipolar disorder with psychotic symptoms | 680 | ||
| EPIDEMIOLOGY, AETIOLOGY AND CLASSIFICATION | 680 | ||
| RISK FACTORS | 681 | ||
| CONVENTIONAL TREATMENT | 682 | ||
| INTEGRATIVE MEDICAL DIAGNOSIS \nAND TREATMENT OPTIONS | 683 | ||
| Chapter 34\rAttention deficit and hyperactivity disorder (ADHD) | 693 | ||
| EPIDEMIOLOGY, AETIOLOGY AND CLASSIFICATION | 693 | ||
| RISK FACTORS | 694 | ||
| CONVENTIONAL TREATMENT | 695 | ||
| INTEGRATIVE MEDICAL DIAGNOSISAND TREATMENT OPTIONS | 695 | ||
| Chapter 35\rChronic fatigue syndrome | 707 | ||
| OVERVIEW | 707 | ||
| AETIOLOGY | 708 | ||
| RISK FACTORS | 709 | ||
| CONVENTIONAL TREATMENT | 710 | ||
| KEY TREATMENT PROTOCOLS | 710 | ||
| Chapter 36\rHuman immunodeficiency virus | 721 | ||
| AETIOLOGY | 721 | ||
| RISK FACTORS | 721 | ||
| CONVENTIONAL TREATMENT | 722 | ||
| KEY TREATMENT PROTOCOLS | 723 | ||
| INTEGRATIVE MEDICAL CONSIDERATIONS | 728 | ||
| Chapter 37\rPolypharmacy and pain management | 736 | ||
| OVERVIEW | 736 | ||
| APPROACHING PATIENTS ON MEDICATIONS | 738 | ||
| PAIN MANAGEMENT | 741 | ||
| PART F\rAppendices | 753 | ||
| Appendix 1\rDrug–herb interaction chart | 754 | ||
| Appendix 2\rChemotherapy drugs and concurrent complementary therapy | 785 | ||
| Appendix 3\rFood sources of nutrients | 816 | ||
| Appendix 4\rLaboratory reference values | 818 | ||
| Appendix 5\rFactors affecting nutritional status | 825 | ||
| Appendix 6\rTaxonomic cross-reference of major herbs | 831 | ||
| Appendix 7\rTraditional Chinese medicine: the six evils | 838 | ||
| Appendix 8\rTraditional Chinese medicine: tongue diagnosis | 840 | ||
| Appendix 9\rTraditional Chinese medicine: pulse diagnosis | 841 | ||
| Appendix 10\rSystematic review of herbal immunomodulators | 842 | ||
| INDEX | 845 |